AIMC Topic: Neural Networks, Computer

Clear Filters Showing 29001 to 29010 of 31376 articles

Prediction of drug-disease associations by integrating common topologies of heterogeneous networks and specific topologies of subnets.

Briefings in bioinformatics
MOTIVATION: The development process of a new drug is time-consuming and costly. Thus, identifying new uses for approved drugs, named drug repositioning, is helpful for speeding up the drug development process and reducing development costs. Existing ...

sAMP-PFPDeep: Improving accuracy of short antimicrobial peptides prediction using three different sequence encodings and deep neural networks.

Briefings in bioinformatics
Short antimicrobial peptides (sAMPs) belong to a significant repertoire of antimicrobial agents and are known to possess enhanced antimicrobial activity, higher stability and less toxicity to human cells, as well as less complex than other large biol...

BioNet: a large-scale and heterogeneous biological network model for interaction prediction with graph convolution.

Briefings in bioinformatics
MOTIVATION: Understanding chemical-gene interactions (CGIs) is crucial for screening drugs. Wet experiments are usually costly and laborious, which limits relevant studies to a small scale. On the contrary, computational studies enable efficient in-s...

GVDTI: graph convolutional and variational autoencoders with attribute-level attention for drug-protein interaction prediction.

Briefings in bioinformatics
MOTIVATION: Identifying proteins that interact with drugs plays an important role in the initial period of developing drugs, which helps to reduce the development cost and time. Recent methods for predicting drug-protein interactions mainly focus on ...

MDF-SA-DDI: predicting drug-drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism.

Briefings in bioinformatics
One of the main problems with the joint use of multiple drugs is that it may cause adverse drug interactions and side effects that damage the body. Therefore, it is important to predict potential drug interactions. However, most of the available pred...

MAResNet: predicting transcription factor binding sites by combining multi-scale bottom-up and top-down attention and residual network.

Briefings in bioinformatics
Accurate identification of transcription factor binding sites is of great significance in understanding gene expression, biological development and drug design. Although a variety of methods based on deep-learning models and large-scale data have bee...

Drug-target interaction predication via multi-channel graph neural networks.

Briefings in bioinformatics
Drug-target interaction (DTI) is an important step in drug discovery. Although there are many methods for predicting drug targets, these methods have limitations in using discrete or manual feature representations. In recent years, deep learning meth...

Identifying multi-functional bioactive peptide functions using multi-label deep learning.

Briefings in bioinformatics
The bioactive peptide has wide functions, such as lowering blood glucose levels and reducing inflammation. Meanwhile, computational methods such as machine learning are becoming more and more important for peptide functions prediction. Most of the pr...

Learning representation for multiple biological networks via a robust graph regularized integration approach.

Briefings in bioinformatics
Learning node representation is a fundamental problem in biological network analysis, as compact representation features reveal complicated network structures and carry useful information for downstream tasks such as link prediction and node classifi...

Stratified neural networks in a time-to-event setting.

Briefings in bioinformatics
Deep neural networks are frequently employed to predict survival conditional on omics-type biomarkers, e.g., by employing the partial likelihood of Cox proportional hazards model as loss function. Due to the generally limited number of observations i...